GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » PE Ratio (TTM)

Harbin Pharmaceutical Group Co (SHSE:600664) PE Ratio (TTM) : 15.44 (As of Jun. 13, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-06-13), Harbin Pharmaceutical Group Co's share price is ¥2.78. Harbin Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.18. Therefore, Harbin Pharmaceutical Group Co's PE Ratio (TTM) for today is 15.44.


The historical rank and industry rank for Harbin Pharmaceutical Group Co's PE Ratio (TTM) or its related term are showing as below:

SHSE:600664' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 13.75   Med: 33.01   Max: 688.33
Current: 15.44


During the past 13 years, the highest PE Ratio (TTM) of Harbin Pharmaceutical Group Co was 688.33. The lowest was 13.75. And the median was 33.01.


SHSE:600664's PE Ratio (TTM) is ranked better than
69.77% of 602 companies
in the Drug Manufacturers industry
Industry Median: 22.945 vs SHSE:600664: 15.44

Harbin Pharmaceutical Group Co's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ¥0.07. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.18.

As of today (2024-06-13), Harbin Pharmaceutical Group Co's share price is ¥2.78. Harbin Pharmaceutical Group Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.20. Therefore, Harbin Pharmaceutical Group Co's PE Ratio without NRI for today is 13.90.

During the past 13 years, Harbin Pharmaceutical Group Co's highest PE Ratio without NRI was 463.75. The lowest was 13.70. And the median was 28.49.

Harbin Pharmaceutical Group Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.20.

During the past 12 months, Harbin Pharmaceutical Group Co's average EPS without NRI Growth Rate was 20.50% per year.

During the past 13 years, Harbin Pharmaceutical Group Co's highest 3-Year average EPS without NRI Growth Rate was 73.10% per year. The lowest was -53.80% per year. And the median was 5.95% per year.

Harbin Pharmaceutical Group Co's EPS (Basic) for the three months ended in Mar. 2024 was ¥0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.18.


Harbin Pharmaceutical Group Co PE Ratio (TTM) Historical Data

The historical data trend for Harbin Pharmaceutical Group Co's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Pharmaceutical Group Co PE Ratio (TTM) Chart

Harbin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 189.50 At Loss 23.67 16.72 20.94

Harbin Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.37 16.45 14.46 20.94 16.39

Competitive Comparison of Harbin Pharmaceutical Group Co's PE Ratio (TTM)

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Pharmaceutical Group Co's PE Ratio (TTM) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's PE Ratio (TTM) falls into.



Harbin Pharmaceutical Group Co PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Harbin Pharmaceutical Group Co's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=2.78/0.180
=15.44

Harbin Pharmaceutical Group Co's Share Price of today is ¥2.78.
Harbin Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Harbin Pharmaceutical Group Co  (SHSE:600664) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Harbin Pharmaceutical Group Co PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Pharmaceutical Group Co (SHSE:600664) Business Description

Traded in Other Exchanges
N/A
Address
Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.
Executives
Lin Guo Ren senior management
Wang Hai Sheng senior management
Liu Bo senior management
Meng Xiao Dong senior management
Xu Hai Ying Directors, senior managers
Liang Chen senior management
Wang Peng Hao senior management
Xiao Qiang senior management
Wei Shuang Ying senior management
Zhou Xing senior management
Bian Ke Supervisors
Sha Mei senior management
Jian Shi Hui Zhu Xi Supervisors
Wang Zhi Fu Supervisors
Jiang Lu Director

Harbin Pharmaceutical Group Co (SHSE:600664) Headlines

No Headlines